Navigation Links
Nuvasive Reports Third Quarter 2008 Financial Results
Date:10/22/2008

2008 2007

Assets

Current assets:

Cash and cash equivalents $104,388 $61,915

Short-term investments 72,157 19,247

Accounts receivable, net 46,072 27,496

Inventory, net 58,418 36,280

Prepaid expenses and other current assets 3,352 1,240

Total current assets 284,387 146,178

Property and equipment, net of

accumulated depreciation 73,159 43,538

Intangible assets, net of accumulated

amortization 57,041 24,496

Long-term marketable securities 45,148 8,536

Other assets 8,892 2,939

Total assets $468,627 $225,687

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued liabilities $20,078 $13,839

Accrued payroll and related expenses 13,853 12,075

Royalties payable 2,310 2,076

Total current liabilities 36,241 27,990

Senior convertible notes 230,000 -

Long-term liabilities 27,226 1,119

Commitments and contingencies

Stockholders' equity:

Common stock 36 35

Additional paid-in capital 374,695 364,469

Accumulated other comprehensive income

(loss) (363) 54

Accumulated deficit (1
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. NuVasive Completes Acquisition of Osteocel Biologics Business
3. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
4. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
5. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
6. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
9. NuVasive to Host Investor Reception on September 11, 2007
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi LifeSciences™ formalized ... specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and ... PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... (BI) advanced cell culture products, announces the availability of BI’s line of human ... Biological Industries, these stem cell differentiation media offer a complete system for multipotency ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3
... NORCROSS, Ga., Aug. 18 Immucor, Inc. (Nasdaq: ... the blood transfusion industry, today announced that its board of directors ... its current stock repurchase program. , , ... million shares available for repurchase. To date in its first fiscal ...
... NEW YORK, Aug. 18 /PRNewswire-Asia-FirstCall/ ... ("the Company" or "AOBO"), a pharmaceutical,company dedicated to improving ... range of prescription and over the counter ("OTC"),products in ... Jinji,Capsules and Boke Nasal Spray, were awarded the designation ...
... ISELIN, N.J., Aug. 18 SyntheMed, Inc. ... the development and commercialization of anti-adhesion products, announced today ... the reduction of adhesions following cardiac surgery, has received ... Federation for use in all patients who undergo open ...
Cached Biology Technology:Immucor Announces 2 Million Share Increase to Stock Repurchase Program 2American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009' 2American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009' 3SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM) 2
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... especially if they,ve been sneaking The highly ... breeding behavior, where non-parents contribute to rearing the offspring ... assumed that male subordinates never gained paternity in the ... online journal PLoS ONE , reveals that some ...
... electoral victory or defeat is influenced by his or ... Stanford University studies of the most recent presidential and ... looking at whether candidates, statements on climate change translated ... and of political science at Stanford, who led two ...
... scientists have received National Science Foundation (NSF) funding to ... understand the behavior of entire ecosystems, part of the ... climate and land-use change. Professor William McDowell ... (NREN) and assistant professor Wilfred Wollheim of NREN and ...
Cached Biology News:Stanford researchers examine impact of 'green politics' on recent national elections 2Stanford researchers examine impact of 'green politics' on recent national elections 3UNH researchers receive NSF grant to 'scale up' stream ecology 2UNH researchers receive NSF grant to 'scale up' stream ecology 3
... Antibody to Cytokeratin 5 / 6 ... molecular weight, basic type of cytokeratin expressed ... cell layers of stratified epithelia as well ... mesothelial cells and mesothelioma. Cytokeratin 6 (56 ...
...
Aldolase A (N-15)...
Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)...
Biology Products: